UK markets closed

NIKKEI 225
38,946.93
-122.75(-0.31%)
HANG SENG
19,220.62
-415.60(-2.12%)
CRUDE OIL
79.38
-0.42(-0.53%)
GOLD FUTURES
2,423.70
-14.80(-0.61%)
DOW
39,839.18
+32.41(+0.08%)
Bitcoin GBP
54,775.24
+931.96(+1.73%)

What pension research reveals about retirement planning

As the cost of living crisis eases, what steps are you taking to build your pension?

BMY Jan 2025 43.000 put

OPR - OPR Delayed price. Currency in USD

Add to watchlist

3.6500

+0.3700

(+11.28%)

As of 11:51AM EDT. Market open.

Business Wire
Bristol Myers Squibb, Taye Diggs and Schizophrenia Community Partner to Empower People with Schizophrenia Through Live Your PosSCZible Campaign
PRINCETON, N.J., May 21, 2024--Bristol Myers Squibb, Taye Diggs and Schizophrenia Community Partner to Empower People with Schizophrenia Through Live Your PosSCZible Campaign
Business Wire
Bristol Myers Squibb Announces Updated Action Date by the U.S. Food and Drug Administration for Subcutaneous Nivolumab (nivolumab and hyaluronidase)
PRINCETON, N.J., May 21, 2024--Bristol Myers Squibb Announces Updated Action Date by the U.S. Food and Drug Administration for Subcutaneous Nivolumab (nivo and hyaluronidase)
Simply Wall St.
Bristol-Myers Squibb Company (NYSE:BMY) is a favorite amongst institutional investors who own 79%
Key Insights Given the large stake in the stock by institutions, Bristol-Myers Squibb's stock price might be vulnerable...